Helvetica Chimica Acta ± Vol. 82 (1999)
1407
26.35; 29.35; 29.45; 29.65; 31.95; 69.83; 70.10; 115.18; 115.42; 116.54; 121.45; 124.98; 125.98; 150.30; 150.57;
157.22. Anal. calc. for C66H110N2O6: C 77.14, H 10.79, N 2.73; found: C 77.11, H 10.71, N 3.37.
(3Z,6Z)-3,6-Bis(3,4,5-tridodecyloxybenzylidene)piperazine-2,5-dione (3e). Yield: 71%. M.p. 89.68. IR
(KBr): 3177, 2928, 2845, 1678, 1628, 1582, 1473, 1448, 1404, 1333, 1240, 1120, 721. 1H-NMR (CDCl3): 0.87 (t, J
6.35, 6 Me); 1.17 ± 1.46 (m, 54 CH2); 1.68 ± 1.86 (m, 6 CH2); 3.94 ± 4.02 (m, 6 CH2O); 6.64 (s, 4 arom. H); 6.90
(s, 2 CHC); 8.08 (s, 2 NH). 13C-NMR (CDCl3): 14.09; 22.68; 26.09; 29.37; 29.64; 30.32; 31.92; 69.39; 73.62;
106.92; 117.16; 125.08; 127.55; 139.06; 153.93; 156.95. Anal. calc. for C90H158N208: C 77.42, H 11.41, N 2.01;
found: C 76.28, H 11.52, N 1.90.
(3Z,6Z)-3,6-Bis(3,4-didodecyloxybenzylidene)-N,N-dimethylpiperazine-2,5-dione (4e). A mixture of 2e
(508 mg, mmol) and MeI (0.078 ml, mmol) was dissolved in THF (5.0 ml), 60% NaH (50.4 mg, mmol) was
added, and the mixture was stirred at r.t. for 8 h. The soln. was concentrated to dryness, and the solid was
redissolved in AcOEt (10 ml). The soln. was washed with HCl (5%). The org. layer was collected and dried.
Light yellow solids were obtained after recrystallization from hot THF. Yield: 83%. M.p. 60.08. IR (KBr): 2921,
2851, 1686, 1627, 1520, 1470, 1426, 1379, 1343, 1269, 1190, 1136, 1024, 810, 756, 716. 1H-NMR (CDCl3): 0.88
(t, J 6.17, 4 Me); 1.26 ± 1.57 (m, 36 CH2); 1.79 ± 1.82 (m, 4 CH2); 3.02 (s, 2 MeN); 3.99 (q, J 6.45, 4 CH2O);
6.82 ± 6.86 (m, 6 arom. H); 7.12 (s, 2 CH2C). 13C-NMR (CDCl3): 14.10; 22.66; 26.01; 29.35; 29.62; 31.56; 31.90;
35.23; 69.00; 69.37; 112.68; 114.90; 121.97; 123.09; 125.76; 129.95; 148.62; 149.68; 162.81. Anal. calc. for
C68H114N2O6: C 77.37, H 10.88, N 2.65; found: C 77.11, H 10.71, N 2.62.
We thank the National Science Council of Taiwan, ROC (NSC-87-2113-M008-007, NSC-87-2113-M008-008)
for the generous support of this work.
REFERENCES
[1] P. G. de Gennes, J. Prost, ꢀThe Physics of Liquid Crystalsꢁ, Clarendon Press, Oxford, 1993; b) D. Demus, Liq.
Cryst. 1989, 5, 75; c) G. Vertogen, W. H. de Jeu, ꢀThermotropic Liquid Crystals: Fundamentalsꢁ, Springer,
Berlin, 1988; d) G. W. Gray, in ꢀAdvances in Liquid Crystalsꢁ, Ed. G. H. Brown, Academic Press, London,
1976, Vol. 1.
[2] a) L. S. Konstantinova, O. A. Rakitin, C. W. Rees, L. I. Souvorova, T. Torroba, A. J. P. White, D. J. Williams,
Chem. Commun. 1999, 73; b) A. Mallia, M. George, S. Das, Chem. Mater. 1999, 11, 207; c) E. Bialecka-
Florjanczyk, A. Orzeszko, I. Sledzinska, E. Gorecka, J. Mater. Chem. 1999, 9, 381; d) H. C. Lin, C. W. Ko, K.
Guo, T. W. Cheng, Liq. Cryst. 1999, 26, 613; e) J. Belmar, M. Parra, C. Zuniga, C. Perez, C. Munoz, A.
Omenat, J. L. Serrano, Liq. Cryst. 1999, 26, 389; f) J. Belmar, M. Parra, C. Zuniga, G. Fuentes, M. Marcos,
J. L. Serrano, Liq. Cryst. 1999, 26, 9.
[3] L. L. Lai, C. H. Wang, W. P. Hsieh, H. C. Lin, Mol. Cryst. Liq. Cryst. 1996, 287, 177.
[4] a) S. Rajappa, M. V. Natekar, in ꢀAdvances in Heterocyclic Chemistryꢁ, Ed. A. Katritzky, Academic Press,
New York, 1993, Vol. 57, pp. 187 ± 289; b) D. T. Witiak, Y. Wei, Progress in Drug Research-Fortschritte der
Arzneimittel-Forschung 1990, 35, 249.
[5] a) C. K. Lai, C. H. Chang, C. H. Tsai, J. Mater. Chem. 1998, 8, 599; b) C. K. Lai, F. G. Chen, Y. J. Ku, C. H.
Tsai, R. Lin, J. Chem. Soc., Dalton Trans. 1997, 4683; c) C. K. Lai, F. J. Lin, J. Chem. Soc., Dalton Trans. 1997,
17; d) C. K. Lai, C. H. Tsai, Y. S. Pang, J. Mater. Chem. 1998, 8, 1355.
[6] a) C. Shin, M. Hayakawa, H. Kato, K. Mikami, J. Yoshimura, J. Chem. Soc., Perkins Trans. 1, 1980, 419;
b) K. W. Blake, P. G. Sammes, J. Chem. Soc., Chem. Commun. 1970, 980.
[7] T. C. Cheam, S, Krimm, Spectrochim. Acta, Part A 1984, 40A, 481.
Received May 3, 1999